ANDE three-lens brief
Evidence-based stock research on ANDE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · RSI at 24 — technically oversold.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- RSI at 24 — technically oversold.
- Underperforming SPY by 16.4pp over 30 days.
- P/E of 9.2 — trading at a value multiple.
- Analyst mean target $90.00 — 65% above current (3 analysts).
ANDE closed at $54.70 (+0.40%) as of 2026-11-12. Market cap: $1.84B. P/E (trailing) 9.2. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 9.2 — trading at a value multiple.; analyst mean target $90.00 — 65% above current (3 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; rSI at 24 — technically oversold.. Last quarter: Revenue $2.83B, net income $46.45M, free cash flow -$423.59M.
Why three lenses on ANDE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ANDE across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ANDE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ANDE brief"></iframe>